The Treatment of Serious Infections in the 1990's
Published in November 1991
Book
Hardback
260 pages
978-0-443-08799-8 (ISBN)
Description
This puts in therapeutic context antimicrobial treatment and the modification of host factors important in the pathogenesis of specific infections. It concentrates on anti-microbial agents and host factors and covers advances in the treatment of serious infection. It also includes coverage of AIDS. Contributors include expert scientists and investigators in the field of infectious diseases.
This puts in therapeutic context antimicrobial treatment and the modification of host factors important in the pathogenesis of specific infections. It concentrates on anti-microbial agents and host factors and covers advances in the treatment of serious infection. It also includes coverage of AIDS. Contributors include expert scientists and investigators in the field of infectious diseases.
This puts in therapeutic context antimicrobial treatment and the modification of host factors important in the pathogenesis of specific infections. It concentrates on anti-microbial agents and host factors and covers advances in the treatment of serious infection. It also includes coverage of AIDS. Contributors include expert scientists and investigators in the field of infectious diseases.
More details
Series
Language
English
Place of publication
London
United Kingdom
Publishing group
Elsevier Health Sciences
Target group
College/higher education
Professional and scholarly
Illustrations
12 half-tones, 26 line drawings, index
Dimensions
Height: 244 mm
Width: 189 mm
Weight
636 gr
ISBN-13
978-0-443-08799-8 (9780443087998)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Content
The relationship between structure and activity of new antimicrobial agents - an emerging science for the development of new therapies of the 1990s; intra-abdominal infections - monotherapy versus combination therapy; treatment of pelvic inflammatory disease - antibiotics, surgery and modifications of inflammation; therapy for sepsis in neutropenic patient; myelopoietic factors in the prevention of infections in neutropenic patients; immunotherapy for septic shock - a process-orientated approach; short-course combination and oral therapies for bacterial endocarditis; treatment of bacterial meninigitis - blocking harmful mediators of bacterial and host origin; the use of antibiotics, corticosteriods, and surgery in the treatment of brain abcesses; therapy for herpes simplex virus infections of the central nervous system; anti-HIV treatment - recent advances in targeted drug development; cryptoccal meningitis in the immunotherapy for AIDs - associated toxoplasmopsis; prevention of HIV infection during the 1990s - criteria for post-exposure prophylaxis for health care providers sustaining occupational exposure to HIV.